This article is part of a Chronicle. See more from this Chronicle Georg Berrisch, Dec 31, 2014 In its Menarini ruling, the European Court of Human Rights held that fines imposed by the Italian antitrust authority for the violation of competition law are criminal charges and that, consequently, the requirements of Article 6 of the European Convention […]
In this issue: In 2014 we published 156 articles in the CPI Antitrust Chronicle. For this last issue of the year, we’re presenting a baker’s dozen articles that highlight the variety, scope, and diversity of the content we presented. We invite you take a look back and see what you may have missed, or reacquaint […]
In this issue: The subject of merger remedies dramatically demonstrates the increasing complexity of antitrust regulation. In this issue, organized by Danny Sokol, we look at problems with conditions imposed on proposed mergers, including (i) dealing with ever-changing high-tech markets, (ii) conflicts across multiple regimes, (iii) competition laws that deal with more than maintaining competitive markets, […]
This article is part of a Chronicle. See more from this Chronicle Kalyani Singh, Nov 24, 2014 Given the sensitivity and direct impact on consumers, it is of little surprise that the pharmaceutical industry—if not an absolute—ranks as one of the most controversial and actively pursued sectors by antitrust authorities across the world. India is […]
In this issue: In the antitrust debate arena, health care topics are the gifts that just keep on giving—always something new to discuss, analyze, or understand. This issue focuses primarily on two segments, product hopping and pay-for-delay. The first paper describes and analyzes, while the next two papers contrast regulatory approaches. Then we present case […]
In this issue: Information exchanges between competitors have long challenged global competition authorities. Whether via trade associations or otherwise, such exchanges can be productive for consumers—enabling cost savings through collective know-how re improving products or production efficiency—or detrimental, hiding price-fixing or bid-rigging. And with data now a global product, such challenges will only increase in […]
In this issue: Last issue we looked at how protectionist sentiments are playing out in Europe; for this issue, we’ve invited four Asian experts to take a look at whether protectionism exists in Asia. The answers differ, present contrasting viewpoints, and even introduce a little irony. And we have three intriguing updates in our Of Special Interest […]
This article is part of a Chronicle. See more from this Chronicle Alex Chisholm, Nelson Jung, Oct 15, 2014 Developments over the past few months have been described as a “volcanic rise in protectionist sentiments from national governments.” General Electric’s bid for Alstom as well as numerous recent takeover proposals in the pharmaceutical sector, in particular […]
In this issue: Protectionist sentiments are becoming more significant in merger control considerations, especially in Europe. Can public interest exemptions or other protectionist considerations bring benefits that would justify potentially harmful side-effects from overriding competition-based analyses? Our first four papers, led by the U.K.’s new CMA, look to answer just that question. And the first paper in our […]
In this issue: Obama Care has brought a classic cost-benefit question in health care to the forefront: How to improve health care while controlling costs? We present a number of analyses, first looking at whether increased insurance coverage compensates for potential losses. Then we discuss several ways a more classic antitrust conflict—preserving competition vs. encouraging […]